微电生理
(688351)
| 流通市值：28.42亿 | | | 总市值：107.11亿 |
| 流通股本：1.25亿 | | | 总股本：4.71亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 223,748,530.83 | 104,099,813.81 | 413,166,794.49 | 290,866,132.55 |
| 营业收入 | 223,748,530.83 | 104,099,813.81 | 413,166,794.49 | 290,866,132.55 |
| 二、营业总成本 | 201,859,987.04 | 92,572,167.93 | 401,537,623.37 | 287,957,417.1 |
| 营业成本 | 89,276,207.09 | 41,052,440.47 | 170,519,238.94 | 119,862,505.9 |
| 税金及附加 | 2,148,395.43 | 1,023,678.65 | 3,128,777.07 | 2,687,180.33 |
| 销售费用 | 62,936,011.57 | 27,366,770.2 | 110,860,672.58 | 80,636,977.44 |
| 管理费用 | 20,753,359.94 | 11,320,386.3 | 42,638,056.89 | 29,905,134.19 |
| 研发费用 | 30,679,975.05 | 13,417,634.91 | 77,401,893.01 | 56,543,925.34 |
| 财务费用 | -3,933,962.04 | -1,608,742.6 | -3,011,015.12 | -1,678,306.1 |
| 其中:利息费用 | 181,842.64 | 105,677.23 | 886,734.64 | 712,180.93 |
| 其中:利息收入 | 1,999,931.06 | 1,088,047.28 | 4,102,580.22 | 3,601,493.58 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 3,691,138.89 | 2,560,608.33 | 11,430,173.67 | 9,040,559.74 |
| 加:投资收益 | 4,712,123.65 | 1,807,889.66 | 8,983,819.55 | 6,648,248.47 |
| 资产处置收益 | 726,244.5 | 726,244.5 | -33,969.45 | - |
| 资产减值损失(新) | -1,755,819.94 | -790,521.71 | -2,971,800.66 | -2,339,522.09 |
| 信用减值损失(新) | -49,376.36 | 59,365.67 | -1,270,362.46 | -143,488.45 |
| 其他收益 | 5,757,847.08 | 2,041,065.69 | 26,757,938.19 | 27,840,968.03 |
| 四、营业利润 | 34,970,701.61 | 17,932,298.02 | 54,524,969.96 | 43,955,481.15 |
| 加:营业外收入 | 9,227.03 | - | 23,661 | 23,661 |
| 减:营业外支出 | 2,163,300 | 60 | 2,422,759.89 | 2,237,402.59 |
| 五、利润总额 | 32,816,628.64 | 17,932,238.02 | 52,125,871.07 | 41,741,739.56 |
| 减:所得税费用 | 148,501.38 | 61,743.88 | 55,508.74 | 15,086.76 |
| 六、净利润 | 32,668,127.26 | 17,870,494.14 | 52,070,362.33 | 41,726,652.8 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 32,668,127.26 | 17,870,494.14 | 52,070,362.33 | 41,726,652.8 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 32,668,127.26 | 17,870,494.14 | 52,070,362.33 | 41,726,652.8 |
| 扣除非经常损益后的净利润 | 20,806,323.47 | 12,560,308.17 | 5,079,782.38 | -752,545.92 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.07 | 0.04 | 0.11 | 0.09 |
| (二)稀释每股收益 | 0.07 | 0.04 | 0.11 | 0.09 |
| 八、其他综合收益 | -18,494.87 | -1,423.97 | 1,450.96 | 522.72 |
| 归属于母公司股东的其他综合收益 | -18,494.87 | -1,423.97 | 1,450.96 | 522.72 |
| 九、综合收益总额 | 32,649,632.39 | 17,869,070.17 | 52,071,813.29 | 41,727,175.52 |
| 归属于母公司股东的综合收益总额 | 32,649,632.39 | 17,869,070.17 | 52,071,813.29 | 41,727,175.52 |
| 公告日期 | 2025-08-27 | 2025-04-30 | 2025-03-28 | 2024-10-22 |
| 审计意见(境内) | | | 标准无保留意见 | |